global glp-1 market size 2030 drugs worldwide 2030| Statista The Global Obesity Therapeutics Market:

It serves many important functions in your body, but much more research is needed to confirm all of its potential benefits

Lose weight with tirzepatide

Risk Profile Ipamorelin is generally considered safer than traditional hormone therapies

- - - In a study of 460,000+ adults on GLP-1s (mostly with T2D): 13% developed nutritional deficiencies in 6 months 22% within 12 months Vitamin D deficiency was most common (13.6%) 3% experienced muscle loss Patients who saw a dietitian were more likely to have deficiencies identifiednot because dietitians caused harm, but because they actually looked

234 Additionally, GLP-1 can reduce blood glucose production by delaying gastric emptying and decreasing appetite, which also contributes to overall blood glucose control